E.I.D. – Parry (India) Limited Board Approves Sale of Stake in Coromandel International Limited

The Board of Directors of E.I.D. – Parry (India) Limited approved a proposal to sell up to 15,00,000 equity shares of Coromandel International Limited (CIL). This transaction represents approximately 0.51% of CIL’s paid-up capital. The sale will be executed through the Open Market. The disclosure noted that the subsidiary, CIL, contributed 76.19% of the parent company’s FY 2024-25 revenue.

Proposal for Divestment of CIL Stake

E.I.D. – Parry (India) Limited announced that its Board of Directors, following a meeting on February 12, 2026, sanctioned a proposal to sell a portion of its equity holding in Coromandel International Limited (CIL). The maximum number of shares slated for sale is 15,00,000 equity shares.

Scale of Holding and Disposal

As of December 31, 2025, the Company held 16,54,55,580 equity shares in CIL, equating to a 56.09% stake in CIL’s paid-up equity share capital. The proposed sale of 15,00,000 shares represents approximately 0.51% of CIL’s total paid-up equity share capital.

Financial Context of Subsidiary

The regulatory filing detailed the financial contribution of the subsidiary, CIL, during the last financial year (FY 2024-25):

  • Revenue contribution stood at ₹24,085.24 Crores, representing 76.19% of the parent company’s total revenue.
  • Net worth contribution totaled ₹11,222.76 Crores, equating to 86.78% of the company’s net worth.

(*Note: Figures are consolidated for FY 2024-25.)

Transaction Details

The consideration for the sale will be determined based upon the market price prevailing on the actual date of sale. The Company intends to execute the divestment through the Open Market. The transaction does not fall under related party transactions and is not considered a slump sale.

The filing confirms that no agreement for sale has been entered into as of the date of the announcement, and the actual completion date is yet to be determined.

Source: BSE

Previous Article

OIL AND NATURAL GAS CORPORATION LIMITED Board Approves Unaudited Financial Results and Declares 2nd Interim Dividend for FY 2025-26

Next Article

Lupin Limited Q3 FY26 Unaudited Financial Results Approved